Generic Sweden AB Statistics
Total Valuation
STO:GENI has a market cap or net worth of SEK 577.72 million. The enterprise value is 540.56 million.
| Market Cap | 577.72M |
| Enterprise Value | 540.56M |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | May 16, 2025 |
Share Statistics
STO:GENI has 12.29 million shares outstanding. The number of shares has increased by 0.05% in one year.
| Current Share Class | 12.29M |
| Shares Outstanding | 12.29M |
| Shares Change (YoY) | +0.05% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 48.58% |
| Owned by Institutions (%) | 13.66% |
| Float | 5.23M |
Valuation Ratios
The trailing PE ratio is 18.50 and the forward PE ratio is 17.74.
| PE Ratio | 18.50 |
| Forward PE | 17.74 |
| PS Ratio | 3.19 |
| PB Ratio | 11.45 |
| P/TBV Ratio | 11.45 |
| P/FCF Ratio | 17.43 |
| P/OCF Ratio | 17.14 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.66, with an EV/FCF ratio of 16.31.
| EV / Earnings | 17.32 |
| EV / Sales | 2.98 |
| EV / EBITDA | 13.66 |
| EV / EBIT | 14.08 |
| EV / FCF | 16.31 |
Financial Position
The company has a current ratio of 2.79
| Current Ratio | 2.79 |
| Quick Ratio | 2.20 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 9,599.75 |
Financial Efficiency
Return on equity (ROE) is 69.80% and return on invested capital (ROIC) is 53.69%.
| Return on Equity (ROE) | 69.80% |
| Return on Assets (ROA) | 31.02% |
| Return on Invested Capital (ROIC) | 53.69% |
| Return on Capital Employed (ROCE) | 67.44% |
| Revenue Per Employee | 8.24M |
| Profits Per Employee | 1.42M |
| Employee Count | 22 |
| Asset Turnover | 2.34 |
| Inventory Turnover | 268.74 |
Taxes
In the past 12 months, STO:GENI has paid 8.13 million in taxes.
| Income Tax | 8.13M |
| Effective Tax Rate | 20.66% |
Stock Price Statistics
The stock price has increased by +5.34% in the last 52 weeks. The beta is 0.67, so STO:GENI's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | +5.34% |
| 50-Day Moving Average | 48.72 |
| 200-Day Moving Average | 54.87 |
| Relative Strength Index (RSI) | 42.25 |
| Average Volume (20 Days) | 12,819 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, STO:GENI had revenue of SEK 181.27 million and earned 31.20 million in profits. Earnings per share was 2.54.
| Revenue | 181.27M |
| Gross Profit | 49.46M |
| Operating Income | 38.40M |
| Pretax Income | 39.33M |
| Net Income | 31.20M |
| EBITDA | 39.58M |
| EBIT | 38.40M |
| Earnings Per Share (EPS) | 2.54 |
Balance Sheet
The company has 37.17 million in cash and n/a in debt, giving a net cash position of 37.17 million or 3.02 per share.
| Cash & Cash Equivalents | 37.17M |
| Total Debt | n/a |
| Net Cash | 37.17M |
| Net Cash Per Share | 3.02 |
| Equity (Book Value) | 50.47M |
| Book Value Per Share | 4.11 |
| Working Capital | 47.90M |
Cash Flow
In the last 12 months, operating cash flow was 33.72 million and capital expenditures -580,000, giving a free cash flow of 33.14 million.
| Operating Cash Flow | 33.72M |
| Capital Expenditures | -580,000 |
| Free Cash Flow | 33.14M |
| FCF Per Share | 2.70 |
Margins
Gross margin is 27.28%, with operating and profit margins of 21.18% and 17.21%.
| Gross Margin | 27.28% |
| Operating Margin | 21.18% |
| Pretax Margin | 21.69% |
| Profit Margin | 17.21% |
| EBITDA Margin | 21.83% |
| EBIT Margin | 21.18% |
| FCF Margin | 18.28% |
Dividends & Yields
This stock pays an annual dividend of 1.60, which amounts to a dividend yield of 3.40%.
| Dividend Per Share | 1.60 |
| Dividend Yield | 3.40% |
| Dividend Growth (YoY) | 6.67% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 63.03% |
| Buyback Yield | -0.05% |
| Shareholder Yield | 3.35% |
| Earnings Yield | 5.40% |
| FCF Yield | 5.74% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |